These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome. Kyrieleis HA; Levtchenko EN; Wetzels JF Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840 [TBL] [Abstract][Full Text] [Related]
3. The response to cyclophosphamide in steroid-sensitive nephrotic syndrome is influenced by polymorphic expression of glutathion-S-transferases-M1 and -P1. Vester U; Kranz B; Zimmermann S; Büscher R; Hoyer PF Pediatr Nephrol; 2005 Apr; 20(4):478-81. PubMed ID: 15717164 [TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Zagury A; de Oliveira AL; de Moraes CA; de Araujo Montalvão JA; Novaes RH; de Sá VM; Monteiro de Carvalho Dde B; Matuck T Pediatr Nephrol; 2011 Jun; 26(6):915-20. PubMed ID: 21399901 [TBL] [Abstract][Full Text] [Related]
5. [Cyclophosphamide in idiopathic nephrotic syndrome: Outcome and outlook]. Berkane M; Adarmouch L; Amine M; Bourrahouat A; Ait Sab I; Sbihi M Nephrol Ther; 2018 Apr; 14(2):85-90. PubMed ID: 29631702 [TBL] [Abstract][Full Text] [Related]
6. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300 [TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependence. Srivastava RN; Agarwal RK; Choudhry VP; Moudgil A; Bhuyan UN; Sunderam KR Int J Pediatr Nephrol; 1985; 6(4):245-50. PubMed ID: 4093243 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome. Wang J; Mao J; Chen J; Fu H; Shen H; Zhu X; Liu A; Shu Q; Du L Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959 [TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome. Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993 [TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up in children with steroid-resistant nephrotic syndrome. Besbas N; Topaloglu R; Saatci O; Bakkaloglu A Clin Pediatr (Phila); 1992 May; 31(5):283-8. PubMed ID: 1582094 [TBL] [Abstract][Full Text] [Related]
17. Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial. Raman V; Krishnamurthy S; Harichandrakumar KT Pediatr Nephrol; 2016 Apr; 31(4):595-604. PubMed ID: 26759000 [TBL] [Abstract][Full Text] [Related]
18. Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome. Mizutani A; Fujinaga S; Sakuraya K; Hirano D; Shimizu T Clin Exp Nephrol; 2019 Feb; 23(2):244-250. PubMed ID: 30121800 [TBL] [Abstract][Full Text] [Related]